Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2022-09-26 00:00:00 ET · period of report 2022-09-22 · accession 0001628280-22-025506 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-09-26	2022-09-22	CLOV	Kouzoukas Demetrios L.	Dir	M - OptEx	—	+25.6K	25.6K	New	—
D	2022-09-26	2022-09-22	CLOV	Kouzoukas Demetrios L.	Dir	A - Grant	$0.00	+20.3K	45.9K	+79%	$0
D	2022-09-26	2022-09-22	CLOV	Kouzoukas Demetrios L.	Dir	M - OptEx	—	0	0	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-09-22	M	A	25,608	—	25,608	D	—	—	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration.
2	Common	Class A Common Stock	2022-09-22	A	A	20,271	$0.00	45,879	D	—	—	(F2) Represents shares of Class A common stock underlying a time-based RSU. One hundred percent of the RSUs will vest on the first anniversary of the Date of Grant, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such date.
3	Derivative	Restricted Stock Unit	2022-09-22	M	A	—	$0.00	0	D	— · — to —	25,608 Class A Common Stock	(F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) One hundred percent of the shares subject to the RSU award vested on the date of the 2022 Annual Meeting.